SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Greg22 who wrote (18081)1/23/1999 11:42:00 PM
From: VLAD  Read Replies (4) of 23519
 
Gr&St,

One invalid assumption--that the price of Vivus should be based on Q4's earning numbers. I say Vivus will show a profit of at least 3 cents and perhaps more. What does this mean in the longer term ie at least 12 months out?

The balance sheets will show that

After restructuring Vivus' cost structure will be in line current demand for MUSE allowing for significant profitability in 1999 as MUSE is launched in Europe and as Vivus signs a domestic partner to domestic sales.

Current analyst's consensus estimates in FY1999 of +0.36 IMO are way too low. I believe Vivus will be able to show earnings in 1999 of at least +0.70. Quarterly earnings will show sequencial increases throughout 1999. What will the stock price trade at if the street accepts such expectations? The hell if I know but I think it should be a lot higher than 2 11/16.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext